Cargando…
SF3B1 mutation is a poor prognostic indicator in luminal B and progesterone receptor-negative breast cancer patients
The purpose of this study was to explore the relationship between SF3B1 mutations and the prognoses of patients with breast cancer. Clinical and SF3B1 mutation data from The Cancer Genome Atlas were analyzed. SF3B1 mutations were evaluated as prognostic factors in all breast cancer patients and spec...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777750/ https://www.ncbi.nlm.nih.gov/pubmed/29383138 http://dx.doi.org/10.18632/oncotarget.22983 |